Cullinan Associates’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $19.6M | Sell |
|
|||||
|
2025
Q2 | $16.4M | Sell |
|
|||||
|
2025
Q1 | $19.2M | Sell |
|
|||||
|
2024
Q4 | $16.7M | Sell |
|
|||||
|
2024
Q3 | $20.4M | Sell |
|
|||||
|
2024
Q2 | $20.7M | Sell |
|
|||||
|
2024
Q1 | $23.1M | Sell |
|
|||||
|
2023
Q4 | $20.2M | Sell |
|
|||||
|
2023
Q3 | $22.5M | Buy |
|
|||||
|
2023
Q2 | $18.6M | Buy |
|
|||||
|
2023
Q1 | $21.1M | Buy |
|
|||||
|
2022
Q4 | $20.3M | Buy |
|
|||||
|
2022
Q3 | $16.3M | Sell |
|
|||||
|
2022
Q2 | $19.2M | Buy |
|
|||||
|
2022
Q1 | $19M | Sell |
|
|||||
|
2021
Q4 | $17.3M | Buy |
|
|||||
|
2021
Q3 | $9.77M | Buy |
|
|||||
|
2021
Q2 | $8.81M | Buy |
|
|||||
|
2021
Q1 | $5.9M | Buy |
|
|||||
|
2020
Q4 | $1.48M | Buy |
|
|||||
|
2020
Q3 | $625K | Sell |
|
|||||
|
2020
Q2 | $877K | Buy |
|
|||||
|
2020
Q1 | $526K | Sell |
|
|||||
|
2019
Q4 | $1.04M | Sell |
|
|||||
|
2019
Q3 | $916K | Buy |
|
|||||
|
2019
Q2 | $742K | Sell |
|
|||||
|
2019
Q1 | $927K | Buy |
|
|||||
|
2018
Q4 | $753K | Hold |
|
|||||
|
2018
Q3 | $773K | Sell |
|
|||||
|
2018
Q2 | $905K | Buy |
|
|||||
|
2018
Q1 | $896K | Buy |
|
|||||
|
2017
Q4 | $674K | Sell |
|
|||||
|
2017
Q3 | $1.93M | Sell |
|
|||||
|
2017
Q2 | $1.72M | Buy |
|
|||||
|
2017
Q1 | $1.53M | Buy |
|
|||||
|
2016
Q4 | $1.45M | Sell |
|
|||||
|
2016
Q3 | $7.17M | Buy |
|
|||||
|
2016
Q2 | $6.96M | Buy |
|
|||||
|
2016
Q1 | $5.64M | Buy |
|
|||||
|
2015
Q4 | $5.12M | Sell |
|
|||||
|
2015
Q3 | $5.45M | Buy |
|
|||||
|
2015
Q2 | $5.42M | Sell |
|
|||||
|
2015
Q1 | $4.79M | Buy |
|